The State of CRISPR & Genome Editing 2025, Wed, Jun 11th, 2025 @ 11:00 AM Mary Ann Liebert, Inc. publishers
It has been 20 years since the term “genome editing” first entered the scientific lexicon. The technology was transformed by the development of CRISPR gene editing in 2012. But the remarkable pace of progress in the first decade has hit some headwinds of late. In particular, the use of CRISPR as a clinical tool has progressed more slowly than anticipated, putting pressure on many gene editing companies to narrow their pipelines to conserve resources and highlighting the uphill challenge to deliver the potential of CRISPR to patients worldwide. Nevertheless, new discoveries are expanding the gene editing toolbox in novel and exciting directions. In The State of CRISPR and Genome Editing virtual summit, GEN brings together an outstanding line-up of pioneers and practitioners in genome editing to provide a compelling and candid overview of the field. Attendees will hear about the latest scientific, technology, commercial and regulatory advances that will enable genome editing to unleash i
